The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,012.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up - UPDATE

Mon, 22nd Oct 2012 08:19

888 Holdings: Morgan Stanley ups target from 125p to 130p, overweight rating kept.Aggreko: Jefferies cuts target from 2,800p to 2,535p, buy rating kept; HSBC downgrades to underweight, target cut from 2,350p to 1,750p; JPMorgan Cazenove cuts target from 2,360p to 2,165p, neutral rating kept; Barclays Capital cuts target from 2,550p to 2,360p, overweight rating kept.Alliance Pharma: Investec ups target from 28p to 28.7p, hold rating kept.ASOS: Investec raises target from 2,450p to 2,700p, buy rating kept.Bunzl: Jefferies ups target from 860p to 880p, underperform rating kept.Circle Oil: Investec keeps buy rating and 80p target.Darty: AlphaValue upgrades from reduce to add.Debenhams: Investec raises target from 114p to 122p, buy rating kept.Devro: Panmure Gordon keeps hold rating and 320p target; Investec keeps buy rating and 355p target.Dixons: AlphaValue upgrades from add to buy.e-Therapeutics: Panmure Gordon cuts target from 76p to 73p, buy rating kept.Fidessa: Merchant Securities cuts target from 1,700p to 1,510p, buy rating kept; Jefferies keeps hold rating and 1,510p target; Investec cuts target from 1,230p to 1,110p, sell rating kept.Hikma Pharmaceuticals: UBS downgrades neutral to sell, 755p unchanged.Jardine Lloyd Thompson: Investec ups target from 692p to 758p, hold rating kept.JD Sports: Seymour Pierce upgrades from hold to buy, target lifted from 800p to 1,000p.Marks & Spencer: Investec keeps sell rating and 275p target.Max Petroleum: Merchant Securities increases target from 4.0p to 4.4p, hold rating kept.Mothercare: HSBC ups target from 180p to 295p, neutral rating kept.Next: Investec keeps hold rating and 3,680p target.Ophir Energy: Jefferies maintains buy rating and 800p target.Paragon Group of Companies: UBS raises target from 254p to 262p, buy rating kept.Petrofac: Liberum Capital downgrades to hold, 1,703p target kept.Provident Financial: JPMorgan Cazenove lifts target from 1,500p to 1,626p, overweight rating kept.RBS: Investec downgrades from hold to sell, 255p target kept.Reckitt Benckiser: Investec maintains hold rating and 3,600p target.Senior: Jefferies maintains buy rating and 223p target; Investec cuts target from 250p to 225p, buy rating kept.Spectris: Panmure Gordon downgrades from buy to hold; Investec upgrades to buy.Spirit Pub: Morgan Stanley ups target from 40p to 55p, underweight rating kept.St James's Place: JPMorgan Cazenove raises target from 417p to 435p, overweight rating kept.Travis Perkins: AlphaValue upgrades from reduce to add.Vodafone: Liberum Capital cuts target from 210p to 205p, buy rating kept.Weir: Panmure Gordon downgrades from buy to hold.Whitbread: Investec keeps sell rating and 1,650p target.William Hill: Barclays Capital ups target from 270p to 280p, underweight rating kept.BC
More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.